Transgenic Vaccines

Transgenic vaccines are biotechnological products that are produced by genetic engineering. The genes of a pathogen, such as a virus or bacteria, are inserted into the genome of an organism, such as a plant or a bacterium, to produce an immunogenic protein. The immunogenic protein can then be extracted and used as a vaccine against the pathogen, inducing an immune response in the vaccinated individual. Transgenic vaccines offer an efficient and cost-effective way to produce vaccines, and are increasingly being used to protect against infectious diseases caused by viruses, bacteria, and parasites. Furthermore, transgenic vaccines can also be used to prevent or treat allergies and cancers, allowing for greater personalization of healthcare.

← Journal of Transgenics

Related Articles

4 article(s) found

Differences in the Alveolar Macrophage Proteome in Transgenic Mice Expressing Human SP-A1 and SP-A2

Full-text HTML Download PDF Download XML

Dynamics of Infections and Number of Vaccines Needed to Avoid Covid-19 in Europe

Full-text HTML Download PDF Download XML

FDA Should Re-evaluate All mRNA Vaccines and Revoke Their Use Authorizations (The Short Version).

Full-text HTML Download PDF Download XML

Expression of Concern: Potential Risks and Unknown Effects of mRNA Vaccines on Population Health (6th Rev). Damages Are Being Materialized

Full-text HTML Download PDF Download XML